First Trust SMID Growth Strength ETF

32.07

+0.31921.01%

Post-market: 32.090.3427+1.08%16:00 EDT

Volume:808

Turnover:25.96K

Market Cap:28.86M

PE:- -

High:32.25

Open:32.25

Low:32.07

Close:31.75

52wk High:34.16

52wk Low:28.35

Shares:900.00K

Float Shares:900.00K

Volume Ratio:0.68

T/O Rate:0.09%

Dividend:0.01

Dividend Rate:0.03%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS

GlobeNewswire

·

Apr 14

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/FSGS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FSGS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FSGS\",,,,,undefined,":{"symbol":"FSGS","market":"US","secType":"STK","nameCN":"First Trust SMID Growth Strength ETF","latestPrice":32.07,"timestamp":1790884188414,"preClose":31.7508,"halted":0,"volume":808,"hourTrading":{"tag":"盘后","latestPrice":32.0935,"preClose":31.7508,"latestTime":"16:00 EDT","volume":7,"amount":224.38700200000002,"timestamp":1790884813505,"change":0.3427,"changeRate":0.010793,"amplitude":0.001685},"delay":0,"changeRate":0.01005328999584258,"floatShares":900002,"shares":900002,"eps":0,"marketStatus":"Post-Mkt","change":0.3192,"latestTime":"10-01 16:00:50 EDT","open":32.245,"high":32.245,"low":32.07,"amount":25957.625391999998,"amplitude":0.005512,"askPrice":48.24,"askSize":200,"bidPrice":16.08,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":31.7508,"sharesOutstanding":950002,"nav":31.73,"aum":28557063.46,"dividendRate":0.000318,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":31.7508,"preClose":31.7508,"latestTime":"07:35 EDT","volume":1,"amount":31.7508,"timestamp":1790854531547,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":32.0935,"preClose":31.7508,"latestTime":"16:00 EDT","volume":7,"amount":224.38700200000002,"timestamp":1790884813505,"change":0.3427,"changeRate":0.010793,"amplitude":0.001685},"volumeRatio":0.681608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FSGS\",,,,,undefined,":{"symbol":"FSGS","floatShares":900002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.681608,"shares":900002,"dividePrice":0.0102,"high":32.245,"amplitude":0.005512,"preClose":31.7508,"low":32.07,"week52Low":28.35,"pbRate":"--","week52High":34.155,"institutionHeld":0,"latestPrice":32.07,"eps":0,"divideRate":0.000318,"volume":808,"delay":0,"ttmEps":0,"open":32.245,"prevYearClose":30.4325,"prevWeekClose":32.0463,"prevMonthClose":31.7508,"prevQuarterClose":31.7508,"fiveDayClose":32.0042,"twentyDayClose":33.495,"sixtyDayClose":31.8591},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FSGS\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FSGS","amount":0.0102,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust SMID Growth Strength ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2024-12-13","symbol":"FSGS","amount":0.3931,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"FIRST TRUST EXCHANGE-TRADED FUND VI FIRST TRUST SMID GROWTH STRENGTH ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FSGS\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":0.3931,"currency":"USD"},{"executeDate":"2026-06-25","recordDate":"2026-06-25","paymentDate":"2026-06-30","value":0.0102,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FSGS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FSGS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627481974","title":"Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS","url":"https://stock-news.laohu8.com/highlight/detail?id=2627481974","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627481974?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:00","pubTimestamp":1776164400,"startTime":"0","endTime":"0","summary":"FILSPARI is the first and only approved medicine for this rare kidney disorder and leading cause of kidney failure Ligand is entitled to a 9% royalty on worldwide net sales of FILSPARI JUPITER, Fla., ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/14/3273192/0/en/Ligand-Partner-Travere-Therapeutics-Receives-Full-FDA-Approval-for-FILSPARI-sparsentan-in-FSGS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4139","LENZ","BK4007","BK4585","FSGS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":41,"code":"91000000","status":"200"}]}}